SEC Form 4 reporting owner

FitzPatrick Margaret M

FitzPatrick Margaret M has filed 5 Form 4 transactions reported between February 20, 2026 and September 1, 2026, as a reporting owner of AN2 Therapeutics, Inc..

Name as filed: FitzPatrick Margaret M

Open-market buys, 24 mo
$12K
1 lines
Open-market sales, 24 mo
None
reported
Companies
1
with Form 4 filings
Latest transaction
Sep 1, 2026
transaction date

Roles and reported holdings

  • ANTXAN2 Therapeutics, Inc.
    Feb 20, 2026 – Sep 1, 2026

    Reporting owner

    Held directly10,708 sh as of Sep 1, 2026 · Form 4

    24 months: $12K bought

Transaction history

All 5 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Sep 1, 2026ANTXOpen-market purchaseCode P · direct2,098$12K@ $5.53Form 4
Mar 19, 2026ANTXGrant or awardCode A · direct23,742—Form 4
Mar 19, 2026ANTXGrant or awardCode A · direct10,362—Form 4
Mar 19, 2026ANTXGrant or awardCode A · direct11,463—Form 4
Feb 20, 2026ANTXGrant or awardCode A · direct20,400—Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.